Ocular repercussions in COVID-19 patients: structural changes of the retina and choroid

References

• Fırat M, Kobat SG. How are central foveal and choroidal thickness affected in patients with mild coronavirus disease 2019 infection? Bosn J Basic Med Sci. 2021;21(6):781–785. doi:10.17305/bjbms.2021.5840.
   Web of Science ®Google Scholar
• Seah I, Agrawal R. Can the coronavirus disease 2019 (COVID-19) affect the eyes? A review of coronaviruses and ocular implications in humans and animals. Ocul Immun Inflamm. 2020;28:391–395. doi:10.1080/09273948.2020.1738501.
   PubMed Web of Science ®Google Scholar
• Pernazza A, Mancini M, Rullo E, et al. Early histologic findings of pulmonary SARS-CoV-2 infection detected in a surgical specimen. Virchows Arch [Internet]. 2020:1–6. http://link.springer.com/10.1007/s00428-020-02829-1.
   Web of Science ®Google Scholar
• Zaimy S, Chong JH, Sankaranarayanany V, Harky A. COVID-19 and multiorgan response. Orphanet J Rare Dis. 2020;21:1–9.
   Google Scholar
• Huang Y, Yang C, Xu XF, Xu W, Liu SW. Structural and functional properties of SARS-CoV-2 spike protein: potential antivirus drug development for COVID-19. Acta Pharmacol Sin. 2020;41(9):1141–1149. doi:10.1038/s41401-020-0485-4.
   PubMed Web of Science ®Google Scholar
• Machhi J, Herskovitz J, Senan AM, et al. The natural history, pathobiology, and clinical manifestations of SARS-CoV-2 infections. J Neuroimmune Pharmacol. 2020;15(3):359–386. doi:10.1007/s11481-020-09944-5.
   PubMed Web of Science ®Google Scholar
• Loon SC, Teoh SCB, Oon LLE, et al. The severe acute respiratory syndrome coronavirus in tears. Br J Ophthalmol. 2004;88(7):861–863. doi:10.1136/bjo.2003.035931.
   PubMed Web of Science ®Google Scholar
• Wu P, Duan F, Luo C, et al. Characteristics of ocular findings of patients with coronavirus disease 2019 (COVID-19) in Hubei Province, China. JAMA Ophthalmol [Internet]. 2020;2019:575–577. http://www.ncbi.nlm.nih.gov/pubmed/32232433.
   Web of Science ®Google Scholar
• Sim R, Cheung G, Ting D, et al. Retinal microvascular signs in COVID-19. Br J Ophthalmol. 2021;106:1308–1312. doi:10.1136/bjophthalmol-2020-318236.
   PubMed Web of Science ®Google Scholar
• Bertoli F, Veritti D, Danese C, et al. Ocular findings in COVID-19 patients: a review of direct manifestations and indirect effects on the eye. J Ophthalmol. 2020;2020:1–9. doi:10.1155/2020/4827304.
   Web of Science ®Google Scholar
• Zor KR, Yıldırım Biçer G, Tutaş Günaydın N, Küçük E, Yılmaz U. Can the coronavirus disease 2019 (COVID-19) cause choroiditis and optic neuropathy? Eur J Inflamm. 2021;19:1–7. doi:10.1177/20587392211059060.
   Web of Science ®Google Scholar
• Gutiérrez-Ortiz C, Méndez-Guerrero A, Rodrigo-Rey S, et al. Miller Fisher syndrome and polyneuritis cranialis in COVID-19. Neurology. 2020;95(5):e601–5. doi:10.1212/WNL.0000000000009619.
   PubMed Web of Science ®Google Scholar
• Li X, Ma X. Acute respiratory failure in COVID-19: is it “Typical” ARDS? Crit Care. 2020;24(1):1–5. doi:10.1186/s13054-020-02911-9.
   PubMed Web of Science ®Google Scholar
• Teuwen LA, Geldhof V, Pasut A, Carmeliet P. COVID-19: the vasculature unleashed. Nat Rev Immunol. 2020;20(7):389–391. doi:10.1038/s41577-020-0343-0.
   PubMed Web of Science ®Google Scholar
• Verdoni L, Mazza A, Gervasoni A, et al. An outbreak of severe Kawasaki-like disease at the Italian epicentre of the SARS-CoV-2 epidemic: an observational cohort study. Lancet. 2020;395(10239):1771–1778. doi:10.1016/S0140-6736(20)31103-X.
   PubMed Web of Science ®Google Scholar
• Grewal DS, Polascik BW, Hoffmeyer GC, Fekrat S. Assessment of differences in retinal microvasculature using OCT angiography in Alzheimer’s disease: a twin discordance report. Ophthalmic Surg Lasers Imaging Retin. 2018;49(6):440–444. doi:10.3928/23258160-20180601-09.
   PubMed Web of Science ®Google Scholar
• Asadi-Pooya AA, Simani L. Central nervous system manifestations of COVID-19: a systematic review. J Neurol Sci. 2020;413(January):116832. doi:10.1016/j.jns.2020.116832.
   PubMedGoogle Scholar
• Baig AM, Khaleeq A, Ali U, Syeda H. Evidence of the COVID-19 virus targeting the CNS: tissue distribution, host–virus interaction, and proposed neurotropic mechanisms. ACS Chem Neurosci. 2020;11:995–998. doi:10.1021/acschemneuro.0c00122.
   PubMed Web of Science ®Google Scholar
• Chiquita S, Rodrigues-Neves AC, Baptista FI, et al. The retina as a window or mirror of the brain changes detected in Alzheimer’s disease: critical aspects to unravel. Mol Neurobiol. 2019;56(8):5416–5435. doi:10.1007/s12035-018-1461-6.
   PubMed Web of Science ®Google Scholar
• Cunha JP, Proença R, Dias-Santos A, et al. OCT in Alzheimer’s disease: thinning of the RNFL and superior hemiretina. Graefes Arch Clin Exp Ophthalmol. 2017;255(9):1827–1835. doi:10.1007/s00417-017-3715-9.
   PubMed Web of Science ®Google Scholar
• Teo KY, Invernizzi A, Staurenghi G, Cheung CMG. COVID-19-Related retinal micro-vasculopathy – a review of current evidence. Am J Ophthalmol. 2022;235:98–110. doi:10.1016/j.ajo.2021.09.019.
   PubMed Web of Science ®Google Scholar
• Lima VL, Soares LCM, Pereira LA, et al. Ophthalmic manifestations among patients surviving COVID-19. Int J Gen Med. 2023;16(May):1747–1755. doi:10.2147/IJGM.S399806.
   PubMedGoogle Scholar
• Sadeghi E, Mahmoudzadeh R. Ocular posterior segment complications following COVID ‑ 19 vaccination. Int Ophthalmol [Internet]. 2023;43:4343–4357. doi:10.1007/s10792-023-02795-y.
   PubMed Web of Science ®Google Scholar
• National Institutes of Health. Treatment guidelines panel. Coronavirus disease 2019 (COVID-19). Nih [Internet]. 2021;2019:1–243. https://www.covid19treatmentguidelines.nih.gov/.%0Ahttps://www.covid19treatmentguidelines.nih.gov/.
   Google Scholar
• Spaide RF, Koizumi H, Pozonni MC. Enhanced depth imaging spectral-domain optical coherence tomography. Am J Ophthalmol. 2008;146(4):496–500. doi:10.1016/j.ajo.2008.05.032.
   PubMed Web of Science ®Google Scholar
• Gül FC, Timurkaan ES. Evaluation of choroidal thickness with OCT in COVID-19 patients with high D-dimer levels. Sci Rep [Internet]. 2022;12(1):16826. doi:10.1038/s41598-022-21579-5.
   PubMed Web of Science ®Google Scholar
• Zapata MÁ, García SB, Sánchez-Moltalvá A, et al. Retinal microvascular abnormalities in patients after COVID-19 depending on disease severity. Br J Ophthalmol. 2022;106(4):559–563. doi:10.1136/bjophthalmol-2020-317953.
   PubMed Web of Science ®Google Scholar
• González-Zamora J, Bilbao-Malavé V, Gándara E, et al. Retinal microvascular impairment in COVID-19 bilateral pneumonia assessed by optical coherence tomography angiography. Biomedicines. 2021;9(3):1–14. doi:10.3390/biomedicines9030247.
   Web of Science ®Google Scholar
• Naderi Beni A, Dehghani A, Kianersi F, et al. Retinal findings of COVID-19 patients using ocular coherence tomography angiography two to three months after infection: ocular appearance recovered COVID-19 patient. Photodiagn Photodyn Ther. 2022;38:102726. doi:10.1016/j.pdpdt.2022.102726.
   PubMed Web of Science ®Google Scholar
• Konuk ŞG, Kılıç R, Türkyılmaz B, Türkoğlu E. Choroidal thickness changes in post-COVID-19 cases. Arq Bras Oftalmol [Internet]. 2022;86(2):431–431. http://aboonline.org.br/export-pdf/6279/86(2)07.pdf.
   Web of Science ®Google Scholar
• Erdem S, Karahan M, Ava S, et al. Evaluation of choroidal thickness in patients who have recovered from COVID-19. Int Ophthalmol [Internet]. 2022;42(3):841–846. doi:10.1007/s10792-021-02049-9.
   PubMed Web of Science ®Google Scholar